Back to News
Market Impact: 0.3
GE HealthCare To Acquire SOFIE Biosciences For $945M;Stock Up
Source: Nasdaq
M&A & RestructuringHealthcare & Biotech
GE HealthCare agreed to acquire SOFIE Biosciences from Trilantic North America for $945 million in cash. The announcement provides no further details on the transaction’s expected financial impact or timing.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
GEHC0.60
More News
- CH Robinson to Buy RXO for $5.8B in Bet on AI Model
- Schneider Electric drops $22.6B on PTC as datacenter boom rains money on infra companies
- C.H. Robinson CEO Dave Bozeman on RXO $5.8B Acquisition
- Why did Mattel stock surge 5% today?
- Brazil Election: Bolsonaro Pushes Lula to Brink as Markets Set to Rally
- Schneider Electric to Acquire PTC for More Than $20 Billion